A kidney transplant left Robert Quinn with an acute bout of sepsis. Since then he has suffered 18 episodes of this disease, which causes 1 in 5 deaths globally. Rather than take things lying down he started a company that is creating tech that can detect sepsis in its early stage, potentially saving millions of lives.

A kidney transplant left Robert Quinn with an acute bout of sepsis. Since then he has suffered 18 episodes of this disease, which causes 1 in 5 deaths globally. Rather than take things lying down he started a company that is creating tech that can detect sepsis in its early stage, potentially saving millions of lives.

A kidney transplant left Robert Quinn with an acute bout of sepsis. Since then he has suffered 18 episodes of this disease, which causes 1 in 5 deaths globally. Rather than take things lying down he started a company that is creating tech that can detect sepsis in its early stage, potentially saving millions of lives. &nbsp;

Robert Quinn shares how a bout of Sepsis inspired him to start Patchd Medical

A deep dive into the often lifelong journeys and struggles of people with infection, pain and other chronic illnesses. Personal and inspiring stories fueling IMB’s pursuit of cutting-edge research.By harnessing expertise in chemistry, structural biology, genomics, cell biology, and bioinformatics, IMB has become Australia’s leading life sciences research institute.

Share Robert Quinn shares how a bout of Sepsis inspired him to start Patchd Medical

Sign up to save your podcasts

Robert Quinn shares how a bout of Sepsis inspired him to start Patchd Medical

Robert Quinn shares how a bout of Sepsis inspired him to start Patchd Medical